April 3, 2019 06:41 AM EDT
Financing

Eu­ro­pean play­ers set up one-stop bac­te­r­i­al strain shop for mi­cro­bio­me-fo­cused drug de­vel­op­ers

Natalie Grover

Reporter

The fer­tile mi­cro­bio­me field is gath­er­ing more steam in Eu­rope. Swiss phar­ma con­tract man­u­fac­tur­er Lon­za is join­ing forces with Den­mark’s bio­science firm Chr Hansen …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times